10β,17α-Dihydroxyestra-1,4-dien-3-one: A Bioprecursor Prodrug Preferentially Producing 17α-Estradiol in the Brain for Targeted Neurotherapy

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Uterotrophic effect of 17α-estradiol, the C17 epimer of the main human estrogen 17β-estradiol, was shown to manifest in animal models at doses lower than those necessary for central outcome raising concerns about its potential to treat maladies of the central nervous system. We introduce here 10β,17α-dihydroxyestra-1,4-dien-3-one (α-DHED) that acts as a bioprecursor prodrug producing 17α-estradiol with remarkable selectivity to the brain and, therefore, without appreciable exposure of the periphery to the parent steroid. This distinguishing feature of α-DHED is shown by using an estrogen-responsive mouse model with complementary LC-MS/MS measurement of drug contents in target tissues. Our data warrant further research to fully establish the potential of α-DHED for a safe and efficacious 17α-estradiol-based neurotherapy.

Original languageEnglish
Pages (from-to)2528-2533
Number of pages6
JournalACS Chemical Neuroscience
Volume9
Issue number11
DOIs
StatePublished - 21 Nov 2018

Fingerprint

Prodrugs
Estradiol
Brain
Estrogens
Neurology
Animals
Central Nervous System
Animal Models
Steroids
Tissue
4-androsten-3-one
Research
Pharmaceutical Preparations
3,16-dihydroxyandrost-5-ene-17,19-dione

Keywords

  • 10β,17α-dihydroxyestra-1,4-dien-3-one
  • 17α-Estradiol
  • ERs binding
  • LC-MS/MS
  • Porsolt swim test
  • brain-selective bioprecursor prodrug
  • ovariectomized mice
  • uterotrophic effect
  • α-DHED

Cite this

@article{a0127d280dd24c6abd6f3c3bacb89e55,
title = "10β,17α-Dihydroxyestra-1,4-dien-3-one: A Bioprecursor Prodrug Preferentially Producing 17α-Estradiol in the Brain for Targeted Neurotherapy",
abstract = "Uterotrophic effect of 17α-estradiol, the C17 epimer of the main human estrogen 17β-estradiol, was shown to manifest in animal models at doses lower than those necessary for central outcome raising concerns about its potential to treat maladies of the central nervous system. We introduce here 10β,17α-dihydroxyestra-1,4-dien-3-one (α-DHED) that acts as a bioprecursor prodrug producing 17α-estradiol with remarkable selectivity to the brain and, therefore, without appreciable exposure of the periphery to the parent steroid. This distinguishing feature of α-DHED is shown by using an estrogen-responsive mouse model with complementary LC-MS/MS measurement of drug contents in target tissues. Our data warrant further research to fully establish the potential of α-DHED for a safe and efficacious 17α-estradiol-based neurotherapy.",
keywords = "10β,17α-dihydroxyestra-1,4-dien-3-one, 17α-Estradiol, ERs binding, LC-MS/MS, Porsolt swim test, brain-selective bioprecursor prodrug, ovariectomized mice, uterotrophic effect, α-DHED",
author = "Katalin Prokai-Tatrai and Vien Nguyen and Laszlo Prokai",
year = "2018",
month = "11",
day = "21",
doi = "10.1021/acschemneuro.8b00184",
language = "English",
volume = "9",
pages = "2528--2533",
journal = "ACS Chemical Neuroscience",
issn = "1948-7193",
publisher = "American Chemical Society",
number = "11",

}

TY - JOUR

T1 - 10β,17α-Dihydroxyestra-1,4-dien-3-one

T2 - A Bioprecursor Prodrug Preferentially Producing 17α-Estradiol in the Brain for Targeted Neurotherapy

AU - Prokai-Tatrai, Katalin

AU - Nguyen, Vien

AU - Prokai, Laszlo

PY - 2018/11/21

Y1 - 2018/11/21

N2 - Uterotrophic effect of 17α-estradiol, the C17 epimer of the main human estrogen 17β-estradiol, was shown to manifest in animal models at doses lower than those necessary for central outcome raising concerns about its potential to treat maladies of the central nervous system. We introduce here 10β,17α-dihydroxyestra-1,4-dien-3-one (α-DHED) that acts as a bioprecursor prodrug producing 17α-estradiol with remarkable selectivity to the brain and, therefore, without appreciable exposure of the periphery to the parent steroid. This distinguishing feature of α-DHED is shown by using an estrogen-responsive mouse model with complementary LC-MS/MS measurement of drug contents in target tissues. Our data warrant further research to fully establish the potential of α-DHED for a safe and efficacious 17α-estradiol-based neurotherapy.

AB - Uterotrophic effect of 17α-estradiol, the C17 epimer of the main human estrogen 17β-estradiol, was shown to manifest in animal models at doses lower than those necessary for central outcome raising concerns about its potential to treat maladies of the central nervous system. We introduce here 10β,17α-dihydroxyestra-1,4-dien-3-one (α-DHED) that acts as a bioprecursor prodrug producing 17α-estradiol with remarkable selectivity to the brain and, therefore, without appreciable exposure of the periphery to the parent steroid. This distinguishing feature of α-DHED is shown by using an estrogen-responsive mouse model with complementary LC-MS/MS measurement of drug contents in target tissues. Our data warrant further research to fully establish the potential of α-DHED for a safe and efficacious 17α-estradiol-based neurotherapy.

KW - 10β,17α-dihydroxyestra-1,4-dien-3-one

KW - 17α-Estradiol

KW - ERs binding

KW - LC-MS/MS

KW - Porsolt swim test

KW - brain-selective bioprecursor prodrug

KW - ovariectomized mice

KW - uterotrophic effect

KW - α-DHED

UR - http://www.scopus.com/inward/record.url?scp=85048056691&partnerID=8YFLogxK

U2 - 10.1021/acschemneuro.8b00184

DO - 10.1021/acschemneuro.8b00184

M3 - Article

C2 - 29843514

AN - SCOPUS:85048056691

VL - 9

SP - 2528

EP - 2533

JO - ACS Chemical Neuroscience

JF - ACS Chemical Neuroscience

SN - 1948-7193

IS - 11

ER -